Virax Biolabs Group Limited has announced a $5 million Private Placement to support working capital and corporate purposes, with H.C. Wainwright & Co. as the placement agent.
Amount Raised
$5 Million
Round Type
Post-IPO Equity
LanarkshireManufacturingBiotechnologyHealth CareTherapeuticsDescription
Virax Biolabs Group Limited has entered into agreements for a private placement of 12,500,000 ordinary shares at $0.40 each, expecting to raise $5 million. The proceeds will be used for working capital and corporate purposes. The offering is set to close on December 4, 2025, subject to conditions. H.C
Quick answer
Virax Biolabs raised $5 Million in a Post-IPO Equity round, dated December 3, 2025. Virax Biolabs is based in Lanarkshire, Scotland, United Kingdom.
- How much did Virax Biolabs raise?
- Virax Biolabs raised $5 Million in a Post-IPO Equity round on December 3, 2025.
- What does Virax Biolabs do?
- Virax Biolabs Group Limited is an innovative biotech company founded in 2013 that focuses on detecting immune responses and diagnosing viral diseases, distributing a range of in-vitro diagnostic test kits while..
- Where is Virax Biolabs based and how big is it?
- Virax Biolabs is based in Lanarkshire, Scotland, United Kingdom. Fundz records about 19 employees.
- Who are the decision-makers at Virax Biolabs?
- Fundz holds 1 contact at Virax Biolabs, including the Founder & Chief Executive Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Manufacturing around the same time
Companies in the same sectors as Virax Biolabs that raised within 45 days of this round, from Fundz verified event records.
- CASI Pharmaceuticals raised $5M on December 27, 2025.
- SymPhysis Medical raised $1.3M (Grant) on November 26, 2025.
- Intensity Therapeutics raised $4M (Post-IPO Equity) on October 31, 2025.
- Novabay raised $134M on January 16, 2026.
- Os Therapies raised $3.5M on January 14, 2026.
- Vivere Oncotherapies raised $10M (Funding Round) on January 13, 2026.
Who to call at Virax Biolabs, and when
A new round usually means Virax Biolabs is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Virax Biolabs raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Virax Biolabs, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Virax Biolabs. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Virax Biolabs raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Virax Biolabs raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.